Cargando…

Transforming Growth Factor-Beta Orchestrates Tumour and Bystander Cells in B-Cell Non-Hodgkin Lymphoma

SIMPLE SUMMARY: Transforming growth factor-beta (TGFB) is a ubiquitously expressed cytokine involved in numerous functions in both normal and cancer cells. Here, we review, for the first time, the evidence of how B-cell lymphoma cells respond to TGFB and utilise TGFB to modulate surrounding cells in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timmins, Matthew A., Ringshausen, Ingo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996985/ https://www.ncbi.nlm.nih.gov/pubmed/35406544 http://dx.doi.org/10.3390/cancers14071772

Ejemplares similares

Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.
por: Stokke, T., et al.
Publicado: (1998)

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma
por: Khan, Muhammad Rahil, et al.
Publicado: (2018)

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013)

Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.
por: Rehn, S., et al.
Publicado: (1995)

B-cell non-Hodgkin lymphoma of the ethmoid sinus
por: Tinoco, Paulo, et al.
Publicado: (2015)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

A composite lymphoma combining a Hodgkin lymphoma and a marginal zone lymphoma transformed into a diffuse large B‐cell lymphoma
por: Auditeau, Claire, et al.
Publicado: (2018)

Bone Marrow Stromal Cells Drive Key Hallmarks of B Cell Malignancies
por: Mangolini, Maurizio, et al.
Publicado: (2020)

B cell non-Hodgkin's lymphoma: rituximab safety experience
por: Mohrbacher, Ann
Publicado: (2005)

Five Cases of Non-Hodgkin B-Cell Lymphoma of the Ovary
por: Senol, Taylan, et al.
Publicado: (2014)

Primary Non-Hodgkin B Cell Lymphoma in a Man
por: Alhabshi, Sh. M. I., et al.
Publicado: (2011)

MicroRNA profiles in B-cell non-Hodgkin lymphoma
por: Getaneh, Zegeye, et al.
Publicado: (2019)

Gastrosplenocolic fistula secondary to non-Hodgkin B-cell lymphoma
por: Yokoyama, Yujiro, et al.
Publicado: (2020)

Diffused mixed B-cell non-Hodgkin lymphoma of mandible
por: Karadwal, Asha, et al.
Publicado: (2020)

Rare Richter Transformation of Chronic Lymphocytic Lymphoma to Hodgkin Lymphoma
por: Buckley, Tinera, et al.
Publicado: (2021)

Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
por: Veeraballi, Sindhusha, et al.
Publicado: (2022)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020)

Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma
por: Kelling, Matthew, et al.
Publicado: (2018)

Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect
por: Wang, Xingmin, et al.
Publicado: (2015)

Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells
por: Tosetti, Francesca, et al.
Publicado: (2018)

Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma
por: Wu, Hao, et al.
Publicado: (2023)

Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report
por: Salvioni Chiabotti, Paolo, et al.
Publicado: (2020)

Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.
por: Stokke, T., et al.
Publicado: (1998)

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
por: Veal, Gareth J., et al.
Publicado: (2016)

Extranodal large B-cell type aggressive non-Hodgkin's lymphoma
por: Batra, Ranmeet, et al.
Publicado: (2014)

Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
por: Katiyar, Richa, et al.
Publicado: (2015)

Infrequent BCL10 Mutations in B‐Cell Non‐Hodgkin's Lymphomas
por: Takahashi, Hidenobu, et al.
Publicado: (1999)

Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas
por: Crisci, Stefania, et al.
Publicado: (2019)

Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease
por: Bonesteele, Grant, et al.
Publicado: (2020)

Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma
por: Jezeršek Novaković, Barbara, et al.
Publicado: (2021)

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
por: Minson, Adrian, et al.
Publicado: (2022)

PB2155: B-CELL NON-HODGKIN’S LYMPHOMAS ASSOCIATED WITH AMYLOIDOSIS
por: Navrátilova, M., et al.
Publicado: (2022)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
por: Hartmann, Sylvia, et al.
Publicado: (2021)

Composite lymphoma associating diffuse large B‐cell lymphoma with classical Hodgkin lymphoma
por: Lauwers, Maïlis, et al.
Publicado: (2022)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022)

Primary T-Cell Non-Hodgkin Lymphoma of the Vagina
por: Herraiz, J. L., et al.
Publicado: (2015)

Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation
por: Das, Jyoti, et al.
Publicado: (2009)

Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation
por: Das, Jyoti, et al.
Publicado: (2009)

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma
por: Bellitti, Emilio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d9i74q1bmr88ule1ua13rdecjd